Association of the histidine-triad nucleotide-binding protein-1 (HINT1) gene variants with nicotine dependence

Pharmacogenomics Journal

Volumn 11, Issue 4, 2011, Pages 251-257

  Jackson, K J ^a   Chen, Q ^a   Chen, J ^a   Aggen, S H ^a   Kendler, K S ^a   Chen, X ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

FTND; histidine triad nucleotide binding protein 1 (HINT1); ND; nucleus accumbens; protein expression; single nucleotide polymorphism

Indexed keywords

HISTIDINE; HISTIDINE TRIAD NUCLEOTIDE BINDING PROTEIN 1; MECAMYLAMINE; MESSENGER RNA; NICOTINE TARTRATE; NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ARTICLE; AUTOPSY; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HAPLOTYPE MAP; HIPPOCAMPUS; HUMAN; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TOBACCO DEPENDENCE; VENTRAL TEGMENTUM;

ADOLESCENT; ADULT; AGED; ANIMALS; AUTOPSY; BRAIN; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HAPLOTYPES; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MECAMYLAMINE; MICE; MICE, 129 STRAIN; MIDDLE AGED; NERVE TISSUE PROTEINS; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; PHENOTYPE; RNA, MESSENGER; SMOKING; TIME FACTORS; TOBACCO USE DISORDER; VIRGINIA; YOUNG ADULT;

ANIMALIA;

EID: 79960646295     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/tpj.2010.41     Document Type: Article

References (30)

1. Klein MG, Yao Y, Slosberg ED, Lima CD, Doki Y, Weinstein IB. Characterization of PKCI and comparative studies with FHIT, related members of the HIT protein family. Exo Cell Res 1998; 244: 26-32. (Pubitemid 28480850)
2. Liu Q, Puche AC, Wang JB. Distribution and expression of protein kinase C interactive protein (PKCI/HINT1) in mouse central nervous system (CNS). Neurochem Res 2008; 33: 1263-1276.
3. Schwab SG, Eckstein GN, Hallmayer J, Lerer B, Albus M, Borrmann M et al. Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol Psychiatry 1997; 2: 156-160. (Pubitemid 27167495)
4. Straub RE, MacLean CJ, O'Neill FA, Walsh D, Kendler KS. Support for a possible schizophrenia vulnerability locus in region 5q22-31 in Irish families. Mol Psychiatry 1997; 2: 148-155. (Pubitemid 27166035)
5. Chen X, Wang X, Hossain S, O'Neill FA, Walsh D, Pless L et al. Haplotypes spanning SPEC2, PDZ-GEF2, and ACSL6 genes are associated with schizophrenia. Hum Mol Genet 2006; 15: 3329-3342. (Pubitemid 44642624)
6. Vawter MP, Barrett T, Cheadle C, Sokolov BP, Wood III WH, Donovan DM et al. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull 2001; 55: 641-650. (Pubitemid 32888383)
7. Vawter MP, Crook JM, Hyde TM, Kleinman JE, Weinberger DR, Becker KG et al. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr Res 2002; 58: 11-20. (Pubitemid 35287279)
8. Vawter MP, Shannon WC, Ferran E, Matsumoto M, Overman K, Hyde TM et al. Gene expression of metabolic enzymes and a protease inhibitor in the prefrontal cortex are decreased in schizophrenia. Neurochem Res 2004; 29: 1245-1255. (Pubitemid 39028877)
9. Chen Q, Wang X, O'Neill FA, Walsh D, Kendler KS, Chen X. Is the histidine triad nucleotide-binding protein (HINT1) gene a candidate for schizophrenia? Schizophr Res 2008; 106: 200-207.
10. Guang W, Wang H, Su T, Weinstein IB, Wang JB. Role of mPKCI, a novel mu-opioid receptor interactive protein, in receptor desensitization, phosphorylation, and morphine-induced analgesia. Mol Pharmacol 2004; 66: 1285-1292. (Pubitemid 39411068)
11. Barbier E, Zapata A, Oh E, Liu Q, Zhu F, Undie A et al. Supersensitivity to amphetamine in protein kinase-C interacting protein/HINT1 knockout mice. Neuropsychopharmacology 2007; 32: 1774-1782. (Pubitemid 47076381)
12. de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 2005; 76: 135-157. (Pubitemid 40812332)
13. Kendler KS, Neale MC, Sullivan P, Corey LA, Gardner CO, Prescott CA. A population-based twin study in women of smoking initiation and nicotine dependence. Psychol Med 1999; 29: 299-308. (Pubitemid 29129315)
14. Prescott CA, Kendler KS. Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins. Am J Psychiatry 1999; 156: 34-40. (Pubitemid 29034877)
15. Fagerstrom KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med 1989; 12: 159-182. (Pubitemid 19191503)
16. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991; 86: 1119-1127.
17. Livak KJ. Allelic discrimination using fluorogene probes and the 50. nuclease assay. Genet Anal 1999; 14: 143-149. (Pubitemid 29095371)
18. Van den Oord EJ, Jiang Y, Riley BP, Kendler KS, Chen X. FP-TDI SNP scoring by manual and statistical procedures: a study of error rates and types. Biotechniques 2003; 34: 610-620, 622.
19. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265. (Pubitemid 40202029)
20. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I et al. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009; 460: 753-757.
21. Scheet P, Stephens M. A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet 2006; 78: 629-644.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(Delta Delta C) method. Methods 2001; 25: 402-408. (Pubitemid 34164012)
23. Jackson KJ, Martin BR, Changeux JP, Damaj MI. Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther 2008; 325: 302-312. (Pubitemid 351439184)
24. Jackson KJ, Kota DH, Martin BR, Damaj MI. The role of various nicotinic receptor subunits and factors influencing nicotine conditioned place aversion. Neuropharmacology 2009; 56: 970-974.
25. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and populationbased linkage analyses. Am J Hum Genet 2007; 81: 559-575. (Pubitemid 47330214)
26. Laviolette SR, Lauzon NM, Bishop SF, Sun N, Tan H. Dopamine signaling through D1-like versus D2-like receptors in the nucleus accumbens core versus shell differentially modulates nicotine reward sensitivity. J Neurosci 2007; 28: 8025-8033.
27. Sellings LH, Baharnouri G, McQuade LE, Clarke PB. Rewarding and aversive effects of nicotine are segregated within the nucleus accumbens. Eur J Neurosci 2008; 28: 342-352.
28. Brunzell DH, Mineur YS, Neve RL, Picciotto MR. Nucleus accumbens CREB activity is necessary for nicotine conditioned place preference. Neuropsychopharmacology 2009; 34: 1993-2001.
29. Liechti ME, Lhuillier L, Kaupmann K, Markou A. Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence. J Neurosci 2007; 27: 9077-9085. (Pubitemid 47312061)
30. Paterson NE, Balfour DJ, Markou A. Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell. Eur J Neurosci 2007; 25: 3099-3108. (Pubitemid 46888800)